Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing
Black Friday Get Elite for just $149.00 Claim Now
Market News Market Pulse Stocks News ETF News Crypto News

Kiniksa Pharmaceuticals International, Plc

Contributing Author

Recent Articles by Kiniksa Pharmaceuticals International, Plc

Nov-11
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London KNSA GlobeNewswire
Oct-27
Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +22.23% GlobeNewswire
Oct-22
Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026 KNSA KNSA -5.03% GlobeNewswire
Sep-04
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference KNSA GlobeNewswire
Aug-07
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference KNSA GlobeNewswire
Jul-28
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +25.03% GlobeNewswire
Jul-23
Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026 KNSA GlobeNewswire
May-29
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Apr-28
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution KNSA +23.48% GlobeNewswire
Apr-23
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 KNSA GlobeNewswire
Apr-08
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST (rilonacept) in Recurrent Pericarditis KNSA GlobeNewswire
Feb-25
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference KNSA GlobeNewswire
Feb-24
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution KNSA -8.21% GlobeNewswire
Feb-19
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 KNSA GlobeNewswire
Jan-12
Kiniksa Pharmaceuticals Provides Corporate Update KNSA GlobeNewswire
Jan-07
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference KNSA GlobeNewswire
Nov-12
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London KNSA GlobeNewswire
Oct-28
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Oct-23
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 KNSA GlobeNewswire
Oct-17
Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis KNSA GlobeNewswire
Aug-28
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Jul-29
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution KNSA +12.32% GlobeNewswire
Jul-24
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 KNSA GlobeNewswire
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)